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Introduction: Potentially inappropriate medication is associated with adverse health and 
functional outcomes, as well as increased health care costs.
Objective: To estimate the prevalence and types of potentially inappropriate medication 
according to the Beers criteria in community-dwelling older persons and to identify the major 
clinical and functional consequences of potentially inappropriate medication during two 
years of following. 
Materials and methods: We conducted a longitudinal, descriptive, and observational study 
that included 400 65-year or older community-dwelling people (48% women) selected by 
simple random sampling in 2012. In 2014, 372 people were re-evaluated and classified 
into two groups based on the presence or absence of potentially inappropriate medication 
through the follow-up period. 
Results: In total, 31% had polypharmacy (5-9 medications) and 1,8% had excessive 
polypharmacy (10 or more medications). The mean of the number of medications was 
higher in the potentially inappropriate medication group (3 vs. 5.78; p<0.001) and 21.9% 
still had the potentially inappropriate medication status during the follow-up; of them, 75% 
had one potentially inappropriate medication and 23% two. The presence of potentially 
inappropriate medication was more frequent among frail and depressed male individuals 
with a bad health self-assessment and comorbidities, especially diabetes mellitus and 
chronic obstructive pulmonary disease. In the group with sustained potentially inappropriate 
medication, we found a worsening health self-assessment, increased frailty, a higher 
incidence of recurrent falls and prevalence of depression, as well as a higher hospital 
admission rate, ambulatory medical consultation, and more prescribed medications. We did 
not find an impact on functional capacity. 
Conclusions: We validated the negative effects of potentially inappropriate medication 
in the long run for the health of older people and, therefore, potentially inappropriate 
medications should be monitored in primary care services to avoid greater risks.
Keywords: Potentially inappropriate medication list; aged; comorbidity; frailty. 
Prevalencia e impacto de la medicación potencialmente inapropiada en ancianos que 
viven en comunidad
Introducción. La medicación potencialmente inapropiada se asocia con consecuencias 
clínicas, geriátricas, funcionales y farmacoeconómicas negativas.
Objetivo. Estimar la prevalencia y los tipos de medicación potencialmente inapropiada 
según los criterios de Beers en ancianos que viven en comunidad y determinar las 
principales consecuencias clínicas y funcionales a lo largo de dos años de seguimiento.
Materiales y métodos. Se hizo un estudio descriptivo, observacional y longitudinal que 
incluyó 400 mayores de 65 años (48 % mujeres) residentes en la comunidad seleccionados 
mediante muestreo aleatorio simple en el 2012. En el seguimiento del 2014 se reevaluaron 
372 de ellos y se clasificaron en dos grupos: quienes a lo largo de los dos años siguieron 
tomando medicación potencialmente inapropiada y quienes no.
Resultados. El 31 % de los ancianos estaban polimedicados, (5 a 9 medicamentos) y 1,8 
% polimedicados de forma excesiva (10 o más medicamentos). El promedio de consumo de 
medicamentos era mayor en el grupo de medicación potencialmente inapropiada (3 Vs. 5,78; 
p<0,001), y el 21,9 % siguieron recibiendo medicación poitencialmente inapropiada durante 
el seguimiento; de ellos, el 75 % recibía un medicamento de este tipo y el 23 %, dos. El uso 
de dicha medicación fue más frecuente en hombres frágiles con una mala percepción de 
la propia salud, depresión y un mayor número de comorbilidades, especialmente diabetes 
mellitus y enfermedad-pulmonar-obstructiva-crónica. En el grupo que siguió recibiendo 
medicación potencialmente inapropiada la percepción de la propia salud empeoró, con un 
incremento de la fragilidad, las caídas recurrentes y la depresión, así como en los ingresos 
hospitalarios y las consultas médicas y mayor cantidad de medicamentos formulados. No se 
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Conclusiones. Se corroboran los efectos negativos a largo plazo de la medicación 
potencialmente inapropiada en la salud de los ancianos, por lo cual se la debe monitorizar 
en la atención primaria para evitar mayores riesgos.
Palabras clave: lista de medicamentos potencialmente inapropiados; anciano; 
comorbilidad; fragilidad.
The accelerated increase in the proportion of older people implies greater 
challenges for modern geriatrics (1). Up to 80 % of people older than 65 
have at least one chronic health condition (2). Usually, these patients are 
more vulnerable to worse outpatient care quality, especially regarding the 
prescription of medications (3). There is a proportional relation between age 
and the number of prescribed medications, as well as with the development of 
problems related to medication (4).
Among these problems related to medication, polymedication or 
polypharmacy is quantitatively determined according to the number of 
medications, and from a qualitative viewpoint, by the use of inadequate 
medications (5). From a quantitative point of view, polymedication is defined 
as the prescription of five or more medications per day, and excessive 
polymedication as the consumption of ten or more medications per day (6). 
Qualitatively, polymedication is determined by the presence of more risks than 
benefits when administering medication given the characteristics of the drug and 
those of the patient, and it is better known as potentially inappropriate medication 
(7). Potentially inappropriate medications are those medications whose individual 
or combined administration should be avoided in older people because they may 
cause more harm than benefits vis a vis safer alternatives (8).
Explicit and implicit assessment strategies have been developed to detect 
potentially inappropriate medications. Implicit strategies are based on judgment 
and require clinical information to be interpreted and assessed, as opposed 
to explicit strategies that are supported in predesigned lists for the elderly 
population to determine which medication is more beneficial than harmful (9). 
In outpatient senior citizens, AGS Beers’ criteria are more efficient for detecting 
potentially inappropriate medications (10,11). Polymedication and the use of 
inappropriate drugs have direct consequences on adverse effects, interactions, 
frequency of consultation in health services, and functional outcomes; they 
are also associated with comorbidity, syndromes, and geriatric conditions, and 
they increase the risk of hospitalization influencing morbidity, mortality, and the 
quality of life of senior patients (12).
The objectives of this study were to estimate the prevalence and types of 
potentially inappropriate medications according to Beers’ criteria in people 
older than 65 living in the community and to describe the main consequences 
of potentially inappropriate medications regarding the clinical, functional, 
syndromic, and geriatric conditions, as well as the use of health services and 
the mental wellbeing during a two-year follow-up (2012-2014).
Materials and methods
Study population
We conducted an analysis of the data obtained from the International 
Mobility in Aging Study (IMIAS), a longitudinal population study among 
1,995 people between 65 and 74 years of age living in the community from 
five different cultural and social contexts: Kingston (Ontario, Canada), Saint-
Hyacinthe (Quebec, Canada), Tirana (Albany), Manizales (Colombia), and 
Natal (Brazil). The objective of the IMIAS was to understand how factors 
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throughout the course of life affect mobility in old people. Its characteristics 
and details have been described elsewhere (13).
In the present study, we used the data of the population from Manizales 
(Colombia): 200 males and 200 females in 2012, and 372 senior citizens 
followed up until 2014 (7 % attrition). The sample selection procedure is shown 
in figure 1. After classifying the participants with potentially inappropriate 
medications in 2012 according to Beers’ criteria, we followed them up 
until 2014 and excluded those who did not comply with this condition: 60 
participants continued to take potentially inappropriate medications and 213 
did not, but they were included in the longitudinal analysis.
Data collection
The information was obtained during house visits from structured 
interviews carried out by previously trained staff. The data regarding 
medications were obtained directly from the patients’ prescriptions and from 
the packaging of drugs prescribed by a doctor or self-prescribed by the patient 
taken during the previous 15 days. All medications were identified using the 
Anatomical Therapeutic Chemical (ATC) Classification suggested by the 
World Health Organization (WHO) (14).
Main measurement
For potentially inappropriate medication, we used Beers’ criteria, an explicit 
description strategy developed in 1991 regularly updated by the American 
Geriatrics Society (AGS) according to new findings recorded in the literature. 
These have been validated in several media and has a better performance for the 
detection of potentially inappropriate medications in people living in communities 
compared with other strategies (15). We used version 2 – 2015 (tables 2, 3, 4) 
and we took into account those medications classified as inappropriate (16,17).
Covariables
Sociodemographic variables. We included questions about general 
demographic aspects, such as age (years); sex (male/female); educational 
level (number of complete formal education years: 0-5, 6-11, or 12 or more); 
marital status (single, married, widow/widower, or separated); income (current 
legal minimum wage at the moment of the interview divided into two groups: 
less than USD$ 300 or more than USD$ 300 per month).
Figure 1. Sample selection process
PIM: Potentially inappropriate medications
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Self-rated health. It was assessed using the question “Do you consider 
your health to be: good, very good, regular, bad, very bad” (18); for the 
analysis, it was dichotomized between good and very good vs. regular, bad, 
and very bad.
Presence of chronic illnesses. Participants were asked if a physician 
had ever told them they had one of the following chronic illnesses: high 
blood pressure, osteoarthrosis/arthritis, heart disease, chronic obstructive 
pulmonary disease, diabetes, cancer, or osteoporosis. Additionally, we 
obtained the number of self-reported chronic conditions (19).
Medications. We recorded the total number of medications or active 
ingredients a person consumed regularly for at least two weeks with a 
specific objective either prescribed by health personnel or self-prescribed. 
They were recorded according to the ATC classification suggested by WHO 
(20). Medication packages and their presentations were checked. Duplicate 
medications were not taken into account for the analysis. According to their 
quantity they were classified into no polymedication (0-4 medications), 
polymedication (5-9 medications), and excessive polymedication (10 or more 
medications) (3).
Visits to the doctor. We registered the number of outpatient visits to the 
doctor in the last year as referred by the participant. 
Hospitalization. We recorded the number of times the person was 
hospitalized in the previous two years. This variable was analyzed only during 
the follow-up (2014).
Geriatric conditions. We took into account the fragility, as defined by Fried, 
et al. (21) and documented in previous publications of the IMIAS study (22).
Recurring falls. This variable referred to the self-report of two or more falls 
in the previous year (23,24).
Depression. We used the depression scale of the Centro de Estudios 
Epidemiológicos (CES-D) (25-27), which has 20 items related to depressive 
symptoms and rated from 0 to 60 points where scores >16 are considered 
suggestive of depression (28).
Cognitive impairment. We applied the Leganés cognitive test, which 
evaluates six cognitive areas: High scores correspond to an adequate 
cognitive functioning and >22 suggest cognitive impairment (28).
Activities of daily living. We asked the participants the following question: “Do 
you have any difficulty to independently perform one of the following activities: 
walking in a room, getting dressed, bathing, eating, climbing stairs, climbing into 
bed, and going to the toilet” (29,30) and then classified them into two groups: 
those who had no difficulties for performing the activities vs. the rest. 
All the procedures were endorsed by the University of Caldas Bioethics 
Committee.
Statistical analysis
We carried out a descriptive analysis (frequency distribution, averages, 
and standard deviation). We did a bivariate analysis using the Student’s t 
test for continuous variables and the chi-squared and Fisher’s exact tests for 
categorical variables. The normality of the continuous variables was evaluated 
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using the Kolmogorov-Smirnov test. We used generalized linear models with 
robust Poisson regression models to estimate prevalence ratios. Multivariate 
logistic regression was used to identify the correlations of taking potentially 
inappropriate medications after the adjustment of the demographic, health, 
and medication variables. We considered p<0.05 as statistically significant. 
The data were analyzed using SPSS™, version 22.0.
Ethical considerations
The study was approved by the ethics committee of the Universidad de 
Caldas. All participants signed the informed consent. According to Resolution 
8430/1993 from the Colombian Ministry of Health on studies with human 
beings, it was considered of minimal risk given that participants had a very 
low probability of suffering any harm as a consequence of the study.
Results
Table 1 shows the characteristics of the sample at the beginning of 
the study (2012) and during follow-up (2014) according to participants’ 
sociodemographic and clinical variables and their geriatric conditions. There 
were significant differences regarding gender: 66.7% of the total population 
with potentially inappropriate medications were males. Regarding the clinical 
status, self-rated health was significantly better (p=0.011) among those 
not taking potentially inappropriate medications. As regards comorbidity, 
participants with potentially inappropriate medications reported an average 
of 2.02 chronic illnesses while those without potentially inappropriate 
medications only reported 1.31 (p=0.000).
The average number of consumed medications was 3.67 (Stangard 
deviation, SD=2.66); a higher consumption was found among participants 
taking potentially inappropriate medications than among those who did not (3 
vs. 5.78; p<0.001); 31% had polymedication (5-9 medications) and 1.8% had 
excessive polymedication (10+ medications). At the two-year follow-up, 21.9% of 
the participants were still taking potentially inappropriate medications of whom, 
75% took one, 23% two, and 0.4% three. The use of potentially inappropriate 
medications was more frequent in males with bad self-rated health, a higher 
number of comorbidities (especially diabetes mellitus and chronic obstructive 
pulmonary disease), who were more fragile and had depression. The most 
frequently taken potentially inappropriate medications were prazosin (alpha 
blockers) by 33% of participants, proton pump inhibitors by 17%, non-steroidal 
anti-inflammatory drugs (NSAID) by 12%, and antihistamines by 7.5%, all of 
which continued to be prescribed two years later (figure 2).
During follow-up, the self-rated health of people taking potentially 
inappropriate medications was worse and their comorbidities increased, 
especially diabetes mellitus, as well as their fragility, which increased 
significantly from 11 to 17% after two years. The number of recurring falls was 
significantly higher in this group too (18.3% vs. 8.5%). Likewise, depression, 
the number of hospitalizations and medical consultations, and the total 
prescribed medications were significantly higher in this group that kept taking 
potentially inappropriate medications after two years.
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Age, average (SD)   69.3   (2.96) 69.1     (2.89) 69.9   (4.15)   0.075   71.4   (3.00)   71.2    (2.95) 72.3   (3.146)   0.081
Gender, n (%)
  0.010   0.010Female 131    (48.0)  111    (52.1) 20    (33.3) 131    (48.0)  111    (52.1) 20    (33.3)
Male 142    (52.0) 102     (47.9) 40    (66.7) 142    (52.0)   40     (47.9) 40    (66.7)
Marital status, n (%)
  0.613   0.389
Single   37    (13.6)   30    (14.1)   7     (11.7)   40    (14.7)   34    (16.0)   6    (10.0)
Married 127    (53.8)  111    (52.1) 36    (60.0) 147    (53.8) 109     (51.2) 38    (63.3)
Widow/Widower   60    (22.0)   50    (23.5) 10    (16.7)   63    (23.1)   51    (23.9) 12    (20.0)
Separated   29    (10.6)   22    (10.3)   7     (11.7)   23      (8.4)   19      (8.9)   4      (6.7)
Education, years, n (%)
  0.838   0.700
0-5 180    (65.9) 139    (65.3) 41    (68.3) 167    (64.8) 137    (64.3) 40    (66.6)
6-11   43    (15.8)   35    (16.4)   8    (13.3)   59    (21.6)   47    (22.1) 12    (20.0)
12 or more   50    (18.3)   39    (18.9) 11    (18.3)   37    (13.6)   29    (13.6)   8    (13.0)
Income, n (%) 
  0.678   0.609Less than USD$ 300 219    (80.2) 172    (80.8) 47    (78.3) 167     (61.2) 132    (62.0) 35    (58.3)
More than USD$ 300   54    (19.8)   41    (19.2) 13     (21.7) 106    (38.8)   81    (38.0) 25     (41.7)
Clinical characteristics
Self-rated health 
  0.011   0.001Excellent/Very good 153    (56.0) 128    (60.1) 25    (41.7) 185     (67.8) 156    (73.2) 29    (48.3)
Regular/Bad/Very bad 120    (44.0)   85    (39.9) 35    (58.3)   88    (32.2)   57    (26.8) 31    (51.7)
Chronic illnesses
Average (SD)     1.47  (1.27)     1.31  (1.14)   2.02 (1.52)   2.02 (1.52)     1.62  (1.31)     1.47 (1.21)   2.16  (1.50) <0.001
High blood pressure, n (%) 158     (57.9) 118     (55.4) 40    (66.7) 40    (66.7) 162    (59.0) 120    (56.3) 41    (68.3)   0.095
Osteoarthritis, n (%)   75     (27.5)   54    (25.4) 21    (35.0) 21    (35.0)   83    (30.4)   60    (28.2) 23    (38.3)   0.131
Heart disease, n (%)   49     (17.9)   35    (16.4) 14    (23.3) 14    (23.3)   60    (22)   46    (21.6) 14    (23.3)   0.774
COPD, n (%)   32     (11.7)   20      (9.4) 12    (20.0) 12    (20.0)   38    (13.9)   25     (11.7) 13     (21.7)   0.050
Diabetes mellitus, n (%)   32     (11.7)   17      (8.0) 15    (25.0) 15    (25.0)   37    (13.6)   19      (8.9) 18    (30.0) <0.001
Osteoporosis, n (%)   35    (12.8)   26    (12.2)   9    (15.0)   9    (15.0)   39    (14.3)   30    (14.1)   9    (15.0)   0.858
Cancer, n (%)   12      (4.4)     6      (2.8)   6    (10)   6    (10)   16      (5.9)     8      (3.8)   8    (13.3)   0.050
Medications
Total, average (SD)     3.67 (2.66)     3.08 (2.3)   5.78 (2.54) <0.001     4.01 (3.149)     3.35 (2.80)   6.38 (3.195) <0.001
Prescribed medications     3.0   (2.41)     2.47 (2.14)   4.88 (2.38) <0.001     3.49 (2.88)     2.87 (2.56)   5.72 (2.90) <0.001
Self-prescribed medications     0.67 (1.03)     0.60 (0.94)   0.90 (1.27)   0.048     0.47 (0.818)     0.44 (0.797)   0.57 (0.89)   0.295
Visits to the doctor in the last 
year, average (SD) 
    4.48 (4.03)     4.0   (3.65)   6.18 (4.80) <0.001     4.7   (4.34)     4,23 (4,29)   6.35 (4.14)   0.001
Hospitalized in the two last 
years, n (%)
---- ---- ---- ----   73    (26.7)   48    (22.5) 25     (41.7)   0.003
Number of times, average (SD) ---- ---- ---- ---- 1.55      (1.00)     4,23 (4,29)   1.96 (1.27)   0.010
Activities of daily living, without 
difficulties
212     (77.6) 170    (79) 42    (70)   0.031 200    (78) 165     (77.4) 35    (58.3)   0.042
Activities of daily living, one or 
more difficulties
  61    (22.4)   43    (21) 18    (30)   0.031   73    (22)   48    (22.6) 25    (41.7)   0.042
Geriatric conditions
Recurring falls, n (%)   45    (16.5)   32    (15.0) 13    (21.7)   0.221   29    (10.6)   18      (8,5) 11     (18.3)   0.028
Fragility 
  0.004   0.003
Vigorous 136    (49.8) 112     (52.6) 24    (40.0) 133    (48.7)  111    (52,1) 22    (36.7)
 Pre-fragile 125    (45.8)   96    (45.1) 29    (48.3) 120    (44.0)   92    (43.2) 28    (46.7)
 Fragile   12      (4.4)     5      (2.3)   7     (11.7)   20      (7.3)   10      (4.7) 10    (16.7)
Fragile (yes), n (%)   12      (4.4)     5      (2.3)   7     (11.7)   0.002   20      (7.3)   10      (4.7) 10    (16.7)   0.002
Depression n (%)   63    (23.1)   43    (20.2) 20    (33.3)   0.033   51    (18.7)   30    (14.1) 21    (35.0) <0.001
Cognitive impairment n (%)   13      (4.7)   10      (4.6)   3      (5.9)   0.90   15      (5.5)   11      (5.1)   4      (6.7)   0.46
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Regarding the outcome in both populations after two years, we did 
not find statistically significant differences among the sociodemographic 
characteristics. On the other hand, 84.3% of the people with good and very 
good self-rated health in 2014 belonged to the group not taking potentially 
inappropriate medications since 2012. From 2012 to 2014 there was an 
increase in the mean of chronic illnesses, especially in the potentially 
inappropriate medications group.
The prevalence of diabetes mellitus increased 5% in the population 
that kept taking potentially inappropriate medications compared to 0.9% 
of those who did not. Fragility increased significantly in both groups at the 
two-year follow-up, but it was more significant in the group taking potentially 
inappropriate medications as 16.7% of those who took them in 2012 were 
fragile in 2014 compared to 4.7% of those who did not. The percentage of 
participants with depression was significantly higher in the group taking 
potentially inappropriate medications. The number of hospitalizations, doctor 
consultations, and total prescribed medications was higher in the group of 
patients taking potentially inappropriate medications since 2012.
Table 2 shows the logistic regression analysis used to analyze the 
associated characteristics in the group of subjects who persisted in taking 
potentially inappropriate medications during the two years under evaluation. 
We found an association between potentially inappropriate medications 
persistence and consequences such as self-rated health, the number 
of chronic illnesses, especially diabetes mellitus, fragility, recurring falls, 
depression, and greater use of health care services. We did not evidence a 
significant impact on functional capacity.
Figure 2. Categories of potentially inappropriate medication prescribed (2012-2014).
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Discussion
We made a longitudinal analysis of potentially inappropriate medications 
establishing its prevalence, assessed comorbidity, and functionality outcomes, 
as well as geriatric syndromes in an elderly population in the community. 
Quantitative polymedication (five or more medications) was present in 31% 
of the study population and 21% of them took potentially inappropriate 
medications, especially heart medication (prazosin), proton pump inhibitors, 
and NSAID. Potentially inappropriate medications were more frequent in 
males with bad self-rated health, a higher number of comorbidities, especially 
diabetes mellitus and chronic obstructive pulmonary disease, who were more 
fragile and depressed. At the two-year follow-up, potentially inappropriate 
medications were associated with adverse health outcomes such as worse 
self-rated health, increased comorbidities, especially diabetes mellitus, 
increased fragility, recurring falls, and variables associated with adverse 
health events including hospitalizations, medical consultations, and the total 
number of prescribed medications.
The prevalence of quantitative polymedication and potentially inappropriate 
medications was within the ranges reported in the literature: approximately 
one third of the elderly population living in the community consumes five 
or more medications (12), and at least one fourth of them took potentially 
inappropriate medications (31). A Spanish study that included citizens older 
than 85 living in the community (5) reported a potentially inappropriate 
medications prevalence of 69% while a Colombian study (11) reported a 6.9% 
in an outpatient elderly population. A Brazilian longitudinal study on potentially 
inappropriate medications (32) found a prevalence of 43.8%, which was 
associated with bad self-rated health, although, contrary to our study, it was 
more frequent in females.
Both at the beginning of the study and at the follow-up, the most frequently 
prescribed potentially inappropriate medications were cardiovascular ones, 
specifically alpha blockers (around 30%), followed by proton pump inhibitors 
without clear indication, and, lastly, by drugs with a direct effect on the central 
*PR (CI): Prevalence ratios (confidence interval); CI=95%
Table 2. Prevalence ratio for various consequences among the subjects with 
potentially inappropriate medications, 2012-2014 (n=60)
Characteristic Significance (p<0.05) PR (CI)
Self-rated health <0.001 2.93 (1.62-5.27)
Number of chronic diseases 
(two or fewer vs. three or more)
<0.001 2.50 (1.34-4.69)
Diabetes mellitus <0.001 4.38 (2.11-9.04)
Fragility 0.004 4.06 (1.60-10.28)
Recurring falls 0.028 2.43 (1.08-5.84)
Depression, CES-D scale >16 
points 
<0.001 3.28 (1.70-6.33)
Hospitalizations in the last two 
years
<0.001 2.45 (1.34-4.50)
Number of hospitalizations in 
the last two years
0.010 3.75 (0.82-17.24)
Number of doctor consultations 
in the last year
0.001 4.22 (1.73-10.29)
Total prescribed medications 
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nervous system, which agrees with findings from other studies (33). More recent 
studies show a high proportion of hypnotic and anticholinergic medication.
A study in Spanish patients over 85 years old reported high prescription of 
hypnotics (benzodiazepine-type) and cardiovascular medications such as loop 
diuretics and NSAID (5). A French study showed that approximately 12% of all 
potentially inappropriate medications were hypnotics (benzodiazepines) and 
almost 10%, anticholinergics (tricyclic antidepressants-type) (34). In Taiwan, 
around 21% of all potentially inappropriate medications were benzodiazepines 
(35) while in the Brazilian study mentioned previously, methyldopa and 
clonazepam prescriptions corresponded to 25% of the total prescribed 
potentially inappropriate medications. In Colombia, the pharmacological group 
most frequently associated with potentially inappropriate medications was 
that of NSAID with almost 12% of prescriptions in this age group (11). In our 
study, proton pump inhibitors without clear indication represented almost 17% 
of all potentially inappropriate medications prescriptions similar to reports from 
other countries such as Pakistan, where they accounted for 25% (36).
The number of prescribed potentially inappropriate medications was 
the same with a small tendency to increase during the two follow-up years, 
which according to the literature could be associated with an increase in 
the medication-medication and medication-comorbidity interactions (37). 
Additionally, in our study, the number of comorbidities during follow-up 
increased suggesting the need for more medications as evidenced at the 
two-year mark. This is the tendency reported in longitudinal studies with an 
increase in comorbidities and, consequently, in polypharmacy and potentially 
inappropriate medications (23,38).
Diabetes mellitus was associated with the potentially inappropriate 
medications group during follow-up. It has been previously noted that 
specific chronic conditions (for instance, mental health disorders or diabetes 
mellitus) could increase the risk of potentially inappropriate medications 
since the medications that are usually administered for their control are 
linked to adverse effects in the elderly population (19). On the other hand, the 
association between potentially inappropriate medications and depression has 
been mentioned before (25,38) and it is likely that in our case, they constituted 
collateral effects of potentially inappropriate medications or medications that 
promote depressive symptoms (38). Along those lines, the deterioration in 
self-perceived health during follow-up would respond to the fact that senior 
patients with the worst self-perceived health think they are sicker and use 
health care services a lot more (32). Likewise, the association of self-rated 
health with illnesses, disability, and functional limitations is clear (39).
Regarding the consequences of geriatric conditions and syndromes and 
potentially inappropriate medications, they have been mostly reported in 
transversal studies (34). On the other hand, the association of increased fragility 
in elderly people and potentially inappropriate medications during follow-up 
was evident, especially those with anticholinergic effects (40). In a transversal 
study in a French population older than 65 years, a proportional association 
among fragility, excessive polymedication, and potentially inappropriate 
medications was found (34); these findings support the recommendation to 
reduce polypharmacy as part of the interventions to manage fragility. As shown 
in various studies (41), the role of potentially inappropriate medications in 
recurring falls due to drowsiness, deterioration of postural reflexes, myorelaxant 
effects, and extrapyramidal symptoms is clear (24).
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As for the use of health care services, we corroborated the association 
between potentially inappropriate medications and the increase in 
hospitalization rates, doctor visits (35), and polymedication. In a recent 
metanalysis of observational studies on potentially inappropriate medications, 
the authors found that it was significantly associated with emergency room 
visits, drug adverse reactions, and hospitalizations. Additionally, the Albacete 
study recently showed that polypharmacy is linked to mortality, incident 
disability, hospitalization, and visits to the emergency room in fragile and pre-
fragile elders. These findings indirectly indicate that physicians are frequently 
prescribing these medications in this age group, and as such, they can be 
held responsible for most of the potentially inappropriate medications and the 
impact they have on people’s health.
Among the strengths of our study, we can mention the documented 
long-term associations of potentially inappropriate medications with 
sociodemographic factors, clinical characteristics, and geriatric conditions in a 
group of elderly citizens in the community. Usually, longitudinal studies are done 
with quantitative polypharmacy, while this one used qualitative polypharmacy. 
Another strength is the direct review of patient prescriptions and medication 
packaging by the health personnel who collected the data, which makes our 
results more reliable. Finally, we included self-prescribed medications in this 
category, which is infrequent in potentially inappropriate medications studies.
Our study also had various limitations: Due to selection filters, the sample 
size might not have been enough to find a significant association among some 
variables. Another limitation was the narrow age range, 65 to 74 years old, 
which limits the generalization of results to populations with higher potentially 
inappropriate medications intake, such as very old or institutionalized people.
In conclusion, polymedication was present in the third part of the 
elderly population living in the community and the fifth part took potentially 
inappropriate medications, especially heart and gastrointestinal medications, 
as well as anti-inflammatories. We corroborated the negative long-term 
effects of potentially inappropriate medications in the health of the elderly, 
especially regarding the deterioration of self-rated health, the presence of 
more comorbidities, like diabetes mellitus and depression, as well as multiple 
geriatric conditions such as fragility, recurring falls, and increased use of health 
care services. Therefore, it is important that health care teams constantly 
monitor these to avoid the risks of polymedication and inappropriate use of 
medication.
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